| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |